Canopy Growth (CGC) Other financing activities (2019 - 2026)
Canopy Growth (CGC) posted Other financing activities of -$8.6 million for Q2 2025, up 40.25% sequentially from -$14.4 million in Q4 2024, and down 160.82% YoY from $14.1 million in Q2 2024.
Canopy Growth (CGC) Other financing activities (2019 - 2026) Analysis & Trends
Canopy Growth has reported Other financing activities for 7 years, with the latest figure at -$8.6 million in Q2 2025.
- Quarterly Other financing activities fell 160.82% year-over-year to -$8.6 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$19.6 million (down 428.72% YoY) and the FY2025 annual result came in at -$16.5 million, changed N/A from the prior year.
- Other financing activities improved to -$8.6 million in Q2 2025 per CGC's latest filing, from -$14.4 million in the prior quarter.
- Over five years, Other financing activities peaked at $20.2 million in Q1 2024 and troughed at -$28.3 million in Q1 2023.
- A 5-year average of -$3.2 million and a median of -$2.1 million in 2021 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2024: Other financing activities tumbled 4429.23% in 2022, then soared 171.4% in 2024.
- Over 5 years, Other financing activities stood at $6.7 million in 2021, then surged by 46.4% to $9.9 million in 2022, then tumbled by 109.91% to -$977666.8 in 2023, then slumped by 1368.43% to -$14.4 million in 2024, then soared by 40.25% to -$8.6 million in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered -$8.6 million, -$14.4 million, and $3.4 million for Q2 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.93 Mn |
| Jun 30, 2026 | -4.93 Mn |
| Dec 31, 2025 | -11.98 Mn |
| Dec 31, 2025 | -11.98 Mn |
| Jun 30, 2025 | -8.58 Mn |
| Jun 30, 2025 | -8.58 Mn |
| Dec 31, 2024 | -14.36 Mn |
| Dec 31, 2024 | -14.36 Mn |
| Sep 30, 2024 | 3.38 Mn |
| Sep 30, 2024 | 3.38 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | 20.21 Mn |
| Mar 31, 2024 | 20.21 Mn |
| Dec 31, 2023 | -977,666.79 |
| Dec 31, 2023 | -977,666.79 |
| Sep 30, 2023 | -8.26 Mn |
| Sep 30, 2023 | -8.26 Mn |
| Jun 30, 2023 | -11.04 Mn |
| Jun 30, 2023 | -11.04 Mn |